Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results
EsoGuard® now fully reimbursed by Medicare nationwide, launching a new phase of accelerating commercialization with record monthly test volume to start the fourth quarterConference call and webcast to be held today, November 12, at 8:30 AM ESTNEW YORK, Nov. 12, 2026 // -- Lucid Diagnostic…